Compare DK & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DK | OCUL |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2017 | 2014 |
| Metric | DK | OCUL |
|---|---|---|
| Price | $34.61 | $8.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $35.41 | $22.33 |
| AVG Volume (30 Days) | 1.3M | ★ 6.9M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | N/A | $10.00 |
| Revenue Next Year | N/A | $102.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $11.03 | $5.79 |
| 52 Week High | $43.50 | $16.44 |
| Indicator | DK | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 38.75 |
| Support Level | $29.34 | $6.78 |
| Resistance Level | $35.45 | $12.63 |
| Average True Range (ATR) | 1.91 | 0.61 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 72.98 | 48.11 |
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.